- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05387161
Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis (ENDO-DIET)
Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis and chrOnic Pelvic Pain
The study aims to investigate the nutritional status and eating habits of women suffering from endometriosis and chronic pelvic pain in relation to describe the possible improvement of clinical symptoms following a nutritional intervention.
The primary aim is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.
The first secondary aim will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some specific areas of the patients (sexual, psychological) together with the quantification of some routine blood chemistry parameters (inflammatory markers, levels of proteins and vitamins) .
The second secondary objective will be aimed at describing the changes in clinical symptoms and the parameters mentioned above in patients based on the severity/stage of the pathologies under study.
Study Overview
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Cinzia Ferraris, PhD
- Phone Number: 3402337242
- Email: cinzia.ferraris@unipv.it
Study Locations
-
-
-
Pavia, Italy, 27100
- Recruiting
- University of Pavia
-
Contact:
- Cinzia Ferraris, PhD
- Phone Number: +39 0382987868
- Email: cinzia.ferraris@unipv.it
-
Principal Investigator:
- Barbara Gardella, Dott.
-
Sub-Investigator:
- Monica Guglielmetti, Dott.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of endometriosis +/- chronic pelvic pain
- No menopause (at least 1 menstrual cycle in the previous 6 months)
- Informed consent from the patient and / or an authorized legal representative
Exclusion Criteria:
- Postmenopause
- Pregnancy
- Hysterectomy or oophorectomy
- Chronic diseases that affect the gastrointestinal absorption of nutrients (celiac disease, Chron's disease, ulcerative colitis, cystic fibrosis)
- History of kidney stones, cancer (except basal cell carcinoma) or diabetes
- Modification in the course of the therapeutic intervention of the therapy for endometriosis
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Observational group
A nutritional assessment will be held with the detection of anthropometric parameters. Each participant will be asked to fill in the SF36, the VAS scales, the KESS questionnaire, the SFFI questionnaire, the Questionnaire PUF and O'Leary/Santn, the BDI and the TAS for an assessment of the psychological component. In addition, patients will be asked to fill in a FFQ of food consumption and a 7 days food diary. Finally, routine blood chemistry tests will also be performed, to which will be added those for measuring the inflammatory state and stool examination for the evaluation of fecal Calprotectin for the measurement of intestinal inflammatory markers. The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative daily diet plan, which must be followed for 6 months. At the end of the 6 months, all anthropometric assessments, blood chemistry and stool tests will be repeated, together with the questionnaires. |
The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative ungrammatical daily diet plan, which must be followed for the entire period of intervention (6 months).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months
|
The outcome will be assessed with repeated measurements using the following parameters: -Evaluation of chronic pelvic pain, dysmenorrhea, dyschezia and dysuria: VAS visual analogue scale, from 0 to 10 points where 10 points indicates worst pain |
6 months
|
|
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (quality of life) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months
|
The outcome will be assessed with repeated measurements using the following parameters: Quality of life: measurement of physical and mental components with SF36 consisting of two components, one physical and one mental. Both fall within a range from 0 to 100 points where higher values are associated with better health |
6 months
|
|
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (intestinal function) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months
|
The outcome will be assessed with repeated measurements using the following parameters: Bowel Function: Knowles-Eccersley-Scott Symptom Questionnaire (KESS) (points) |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Sexual Function
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Sexual Function: FSFI questionnaire (points) |
6 months
|
|
To describe and evaluate the impact of the nutritional intervention by describing the changes in Urinary function and bladder pain
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Urinary function and bladder pain: PUF and O's Leary / Sant questionnaire (points) |
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component about Depression
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Beck Depression Inventory (BDI) (points) |
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following questionnaires: Alexithymia Scale (TAS) questionnaire (points) |
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some routine blood chemistry parameters
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following routine blood chemistry parameters: Measure Ca125 (unità/ml) and Vitamin D (ng/ml) |
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Intestinal inflammatory marker
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following test: fecal calprotectin (mg/kg) |
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some Inflammatory markers
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following Inflammatory markers: IL-6 and IL-1β values (pg/ml)
|
6 months
|
|
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in measurement of proteins
Time Frame: 6 months
|
The outcomes necessary to respond to the secondary objective are the administration of the following measurement of proteins: C-reactive protein values (mg/dL)
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Barbara Gardella, Dott, IRCCS Policlinico San Matteo
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-ENDODIET
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on Nutritional intervention
-
Clinica Universidad de Navarra, Universidad de...Completed
-
China-Japan Friendship HospitalRecruiting
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
Jorge Azorin LopezInstituto de Investigación Sanitaria y Biomédica de AlicanteCompletedBody Image | Executive Function (Cognition) | Obesity &Amp;Amp;Amp; OverweightSpain
-
Erasmus Medical CenterNational Institute for Public Health and the Environment (RIVM); Netherlands...CompletedShift-Work Related Sleep DisturbanceNetherlands
-
Arkansas Children's Hospital Research InstituteNot yet recruiting
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedObesity | OverweightUnited States
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedHypertension | Diabetes | Type 2 Diabetes Mellitus | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 2 in Obese | Diabetes Mellitus Non-insulin-dependentBrazil
-
Harokopio UniversityCompletedQuality of Life | Body Weight Changes | Overweight and Obesity | Health Status | Gene-diet InteractionsGreece
-
Central Hospital, Nancy, FranceUnknown